Facing a challenging diagnosis of metastatic urologic cancer, one of the state’s top communications professionals leans into her job, laughter and love.

Estrogen-lowering aromatase inhibitors are frequently prescribed to women with ovarian and uterine cancers. New research sheds light on how side effects impact these patients.

Researchers have made strides toward targeting cancer in a new way. Through a collaboration between institutions and various scientific disciplines, scientists found a new way to attack a previously undruggable tumor suppressor.

A U-M law student, who passed of breast cancer in 2019, is remembered by her family and school in a special way.

An innovative way of assessing clinical trial-related imaging could reduce the kinds of errors that can distort results, study finds.

An ovarian cancer diagnosis gave one 26-year-old patient new perspectives on life and adventure.

Michigan Medicine’s Rogel Cancer Center discusses updated recommendations on screening for BRCA1 and BRCA2 genetic mutations.